LivaNova (LIVN) FCF Payout Ratio (2016 - 2017)
LivaNova's (LIVN) quarterly FCF Payout Ratio came in at 0.21 in Q1 2017, down 89.3% year-over-year from 1.95 in Q1 2016, and up 2108.62% quarter-over-quarter from 0.01 in Q4 2016.
Powered by 
Analysis
LivaNova (LIVN) FCF Payout Ratio (2016 - 2017) Analysis & Trends
LivaNova has disclosed FCF Payout Ratio across 2 years of filings, most recently posting 0.21 for Q1 2017.
- In Q1 2017, FCF Payout Ratio fell 89.3% year-over-year to 0.21; the TTM figure through Mar 2017 stood at 0.13 (changed N/A YoY), while the FY2016 annual figure was 0.12, changed N/A from the prior year.
- FCF Payout Ratio came in at 0.21 for Q1 2017 at LivaNova, up from 0.01 in the prior quarter.
- In the past five years, FCF Payout Ratio ranged from a high of 1.95 in Q1 2016 to a low of 0.01 in Q4 2016.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 0.55 |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 0.71 |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 0.32 |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 0.22 |
| 10 | LivaNova | 4.34 Bn | 3.82 Bn | 273.67 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2017 | 0.21 |
| Dec 31, 2016 | -0.01 |
| Sep 30, 2016 | 0.12 |
| Mar 31, 2016 | 1.95 |